S.B. 189 Enrolled

1

ONCOLOGY INSURANCE AMENDMENTS
2 2013 GENERAL SESSION
3 STATE OF UTAH
4 Chief Sponsor: Curtis S. Bramble
5 House Sponsor: Brad R. Wilson
6
7 LONG TITLE
8 General Description:
9 This bill amends the Accident and Health Insurance part of the Contracts in Specific
10 Lines chapter of the Insurance Code.
11 Highlighted Provisions:
12 This bill:
13 . defines terms;
14 . provides that if a health insurer covers both oral chemotherapy and intravenous
15 chemotherapy, the insurer:
16 . shall apply the same cost sharing requirements to both oral chemotherapy and
17 intravenous chemotherapy; or
18 . shall not impose a cost sharing for oral chemotherapy that exceeds $300, if the
19 insurer imposes different cost sharing for oral chemotherapy and intravenous
20 chemotherapy;
21 . prohibits a health insurer from increasing the cost sharing for oral or intravenous
22 chemotherapy for the purpose of achieving compliance with this section; and
23 . gives the Insurance Department administrative rulemaking authority.
24 Money Appropriated in this Bill:
25 None
26 Other Special Clauses:
27 None
28 Utah Code Sections Affected:
29 ENACTS:

30 31A-22-641, Utah Code Annotated 1953
31
32 Be it enacted by the Legislature of the state of Utah:
33 Section 1. Section 31A-22-641 is enacted to read:
34 31A-22-641. Cancer treatment parity.
35 (1) For purposes of this section:
36 (a) "Cost sharing" means the enrollee's maximum out-of-pocket costs as defined by the
37 health benefit plan.
38 (b) "Health insurer" is as defined in Subsection 31A-22-634 (1).
39 (c) "Intravenously administered chemotherapy" means a physician-prescribed cancer
40 treatment that is used to kill or slow the growth of cancer cells, that is administered through
41 injection directly into the patient's circulatory system by a physician, physician assistant, nurse
42 practitioner, nurse, or other medical personnel under the supervision of a physician, and in a
43 hospital, medical office, or other clinical setting.
44 (d) "Oral chemotherapy" means a United States Food and Drug
45 Administration-approved, physician-prescribed cancer treatment that is used to kill or slow the
46 growth of cancer cells, that is taken orally in the form of a tablet or capsule, and may be
47 administered in a hospital, medical office, or other clinical setting or may be delivered to the
48 patient for self-administration under the direction or supervision of a physician outside of a
49 hospital, medical office, or other clinical setting.
50 (2) This section applies to health benefit plans renewed or entered into on or after
51 October 1, 2013.
52 (3) A health benefit plan that covers prescribed oral chemotherapy and intravenously
53 administered chemotherapy shall:
54 (a) except as provided in Subsection (3)(b), ensure that the cost sharing applied to the
55 covered oral chemotherapy is no more restrictive than the cost sharing applied to the covered
56 intravenously administered chemotherapy; or
57 (b) if the cost sharing for oral chemotherapy is more restrictive than the cost sharing for

58 intravenous chemotherapy, the health benefit plan may not apply cost sharing for the oral
59 chemotherapy that exceeds $300 per filled prescription.
60 (4) (a) A health insurer shall not increase the cost sharing for intravenously
61 administered chemotherapy for the purpose of achieving compliance with this section.
62 (b) The commissioner may adopt administrative rules in accordance with Title 63G,
63 Chapter 3, Utah Administrative Rulemaking Act, to enforce the provisions of this section.

[Bill Documents]